Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. GW Pharmaceuticals.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

NORML

JUNE 13, 2019

Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Certain conditions require more cannabinoids than others. The reality is that cannabinoids have very individualized effects on human beings. Are you paying too much for medical marijuana?

Marijuana 277

Marijuana Dispensary Patients Retail 277

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). This, the authors say, “is well below the dose commonly associated with pharmaceutical products (e.g. CBD, which constitutes a $2,770.8

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

APRIL 22, 2021

Patent protects Supera-CBD, a preclinical cannabidiol derivative that targets cannabinoid receptor type 2 for the treatment of neuroinflammatory and neurodegenerative… Read More.

Cannabinoids 75

Cannabinoids Pharmaceutical Treatment CBD 75

Cannabis Law Report

AUGUST 23, 2021

Oxford Cannabinoid Technologies Holdings plc. Pre-Close Trading Update; US OTC QB Market Application. & & Notice of 2021 Final Results. . Details of a presentation to investors via the InvestorMeet Platform will be announced shortly. Since the year-end, the £2.6

Cannabinoids 98

Cannabinoids Research and Development Clinical Trials Packaging 98

Cannabis Law Report

AUGUST 9, 2021

Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

Cannabis Law Report

SEPTEMBER 8, 2021

The mission of the United Cannabis Business Association is to establish a comprehensive, statewide cannabinoid policy. Comprehensive cannabinoid policy provides for fair and equal regulation of all cannabinoids, regardless of their source or how they were derived.

Cannabinoids 95

Cannabinoids Policy Advocacy Hemp 95

The Fresh Toast

DECEMBER 31, 2020

Even though pharmaceutical drugs and OTC pain-relievers are typically used to help manage fibromyalgia, cannabinoids like CBD and THC are being considered more now than ever before. Fibromyalgia And Cannabis: What The Latest Research Says. If you had to guess, how many people in the United States do you think live with fibromyalgia?

Pharmaceutical 133

Pharmaceutical Cannabinoids THC CBD 133

Leafwell

JANUARY 15, 2021

As common wisdom knows, marijuana is reputed to be the world’s safest drug, whether those proactive cannabinoids are purchased and ingested through the pharmaceutical or artisanal marketplaces. We believe knowledge is power and Leafwell seeks to educate not only patients but medical professionals as well.

Pharmaceutical 117

Pharmaceutical Education Cannabinoids Patients 117

Leafwell

JANUARY 15, 2021

As common wisdom knows, marijuana is reputed to be the world’s safest drug, whether those proactive cannabinoids are purchased and ingested through the pharmaceutical or artisanal marketplaces. We believe knowledge is power and Leafwell seeks to educate not only patients but medical professionals as well.

Pharmaceutical 117

Pharmaceutical Education Cannabinoids Patients 117

FloridaMarijuana.net

JUNE 22, 2018

Ethan Russo suggested that Irritable Bowel Syndrome (IBS), along with fibromyalgia, migraine, and other related conditions, may be linked to an endocannabinoid deficiency ; treatable with cannabinoid medicine. If so, have you felt a difference between the antibiotics or other pharmaceuticals vs. medical marijuana? Yes, I have.

Hybrid 189

Hybrid Marijuana Sativa Nerve Pain 189

Cannabis Law Report

JULY 28, 2021

On 1 June 2021, the Group announced an agreement with Voisin Consulting SARL (“VC”), a life sciences consultancy comprising over 200 professionals in the UK, US and India, with expertise in medical devices, cannabinoids, neurological disorders and addictions.

Cannabinoids 81

Cannabinoids Clinical Trials Safety Medicine 81

Project CBD

FEBRUARY 1, 2023

Anyone who has paid any attention to the cannabis “wellness” industry in recent years — whether through state medical and recreational programs or the free-for-all national CBD market — will be familiar with cannabinoid-infused topicals marketed to treat minor aches and pains.

Conditions 130

Conditions THC CBD Cannabinoids 130

CannaTech

NOVEMBER 6, 2019

The Cannabinoid Buyer’s Needs of Tomorrow. But is this growth serving the needs of cannabinoid buyers? This directly impacts the end cannabinoid buyer. Compliance, regulation, and consistency will be a hallmark of our Responsibility as productive members of this cannabinoid Society.

Cannabinoids 74

Cannabinoids Wellness and Beauty Supply Chain Compliance 74

Cannabis Law Report

NOVEMBER 12, 2021

THE Chairman of a recently-listed UK pharmaceutically-focused cannabis company has stood down after a breach of market rules. Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP).

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Cannabis Law Report

DECEMBER 3, 2020

3, 2020 /PRNewswire/ — Pure Jamaican Limited , provider of pharmaceutical cannabinoids, genetics and consumer packaged goods products in large volumes for … Read More. MIAMI , Dec.

Pharmaceutical 64

Pharmaceutical Legislation Packaging Cannabinoids 64

Cannabis Law Report

DECEMBER 6, 2022

Cannabinoid receptors are currently the most popular targets for CNS in preclinical development, with 391 drugs tagged in total. In 2022, a surge in the pipeline has led […].

Cannabinoids 52

Cannabinoids Pharmaceutical Treatment Law 52

FloridaMarijuana.net

OCTOBER 5, 2018

THC and CBD are two popular cannabinoids, and have been used medicinally for centuries. In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. Cannabis possesses healing properties which can aid in a patient’s overall healthcare routine.

Terpenes 181

Terpenes Strains Oil Medicine 181

Cannabis Law Report

MARCH 26, 2022

Jazz Pharmaceuticals is investing £75m in a plant based at Kent Science Park (KSP) in Sittingbourne, Kent. ” ‘Strategic investment’ Jazz Pharmaceuticals currently manufactures the extract, active pharmaceutical ingredients and the formulated drug products at KSP, occupying 12 buildings with more than 400 employees.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. percent on a dry weight basis.”

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

The Cannigma

FEBRUARY 1, 2023

Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

The Cannigma

NOVEMBER 16, 2022

6 medicinal plants that pharmaceuticals can't replace. A 2017 review of research surrounding the ECS and the esophagus noted, “The presence of cannabinoid receptors in the esophagus, specifically those affecting [esophageal relaxation], offers a potential therapeutic target for treating GERD.”. Related Stories.

Digestion 123

Digestion Cannabinoids Pharmaceutical THC 123

Medical Marijuana Program Connection

OCTOBER 6, 2023

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) (“Anebulo”), today announced. Read More

Pharmaceutical 49

Pharmaceutical Cannabinoids Business 49

The Cannigma

FEBRUARY 8, 2021

These terms are understood to refer to Cannabis sativa plants containing less than a legally specified amount of the cannabinoid ?-9-tetrahydrocannabinol. Following the example of artificial analogues of nicotine, neonicotinoids , these artificially produced cannabinoids could be termed neo-cannabinoids. 9-tetrahydrocannabinol.

Cannabinoids 136

Cannabinoids Sativa Policy Hemp 136

FloridaMarijuana.net

JULY 6, 2018

Patients can suffer from the disease itself, or from the side effects of chemotherapy and other pharmaceuticals medications. Additionally, the NCI recognizes that cannabinoids “may have benefits in the treatment of cancer-related side effects.”.

Strains 189

Strains Indica Nerve Pain Hybrid 189

FloridaMarijuana.net

JUNE 19, 2018

Sometimes traditional veterinary pharmaceuticals may not always be effective for dogs and cats and the side-effects may interfere with a pet’s quality of life. These are administered similar to pharmaceuticals, but without the harmful side effects. When a pet is ill, it can feel like a member of the family is suffering.

Pets 186

Pets CBD Tincture Oil 186

Cannabis Law Report

JUNE 17, 2021

This landmark investment and strategic transaction solidifies Brains’ position as one of the leading pharmaceutical companies in the cannabinoid (CBD) sector. To have the confidence of DSM in this next round solidifies Brains strategic position within the pharmaceutical industry,” said Brains’ CEO & Chairman Rick Brar.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Events 105

Cannabis Law Report

DECEMBER 10, 2022

BusinessCann reports Oxford Cannabinoid Technologies (OCT) has seen its share price jump by more than 20% this week after announcing that its CEO Dr John Lucas would be stepping down. The pharmaceutical company announced on Monday, December 5 that Dr Lucas would leave the company by the end of the year, staying on until then […].

Cannabinoids 52

Cannabinoids Pharmaceutical Compliance Compliance 52

Veriheal

MARCH 9, 2021

A team of researchers at Australia’s University of Queensland and at Botanix Pharmaceuticals Limited found, for the first time, that CBD is effective in killing Gram-negative bacteria which could mean that a new class of antibiotics can be developed for bacteria which is resistant to other forms of pharmaceutical medications. .

Research and Development 109

Research and Development Pharmaceutical Cannabinoids CBD 109

MJ Business Attorneys

JUNE 29, 2018

DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3%

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Project CBD

SEPTEMBER 12, 2023

He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals. According to a 2012 study by University of Bonn scientist Andras Bilkei-Gorzo: “On the cellular level, the cannabinoid system regulates the expression of brain-derived neurotrophic factor and neurogenesis.”

Chronic Pain 228

Chronic Pain Treatment Cannabinoids Research and Development 228

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105